TauRx recognized as a Technology Innovation leader in the neurodegenerative disease management industry
TauRx recognized as a Technology Innovation leader in the neurodegenerative disease management industry
ABERDEEN, Scotland and Singapore, 11 June 2019 – TauRx, a leader in neurodegenerative disease research, today announced that it is the recipient of Frost & Sullivan’s 2019 Asia Pacific Neurodegenerative Disease Management Technology Innovation Award.
Read more here.
TauRx recognized as Technology Innovation leader
– TauRx, a leader in neurodegenerative disease research, today announced that it is the recipient of Frost & Sullivan’s 2019 Award
Recent News
TauRx celebrates winning the Research & Development Achievement category at the Pharma Industry Awards UK 2023.
Oct 25, 2023
GT Diagnostics announces release of self-administered assessment tool aiding diagnosis of dementia, HiPAL Pro.
Sep 05, 2023
#AAIC23 may have come to a close, but we left Amsterdam with key insights that will drive our work this year.
Jul 21, 2023
TauRx’s hydromethylthionine mesylate (HMTM) demonstrates significant reduction in neurodegeneration in Alzheimer’s Disease (AD)
Jul 16, 2023